V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20216578 | 20175074 | 1.78 | 83.05 | Adjuvant (A) | 2019-05-31 | 2019-10-13 | HCX (Cape + Cisp + Tras) - Main | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101509275 |
| 20216581 | 20175075 | 1.82 | 52.45 | Palliative (P) | 2016-11-29 | 2017-04-19 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100401974 |
| 20216598 | 20175076 | 1.77 | 86.2 | Palliative (P) | 2017-08-22 | 2017-09-13 | HCX | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100329184 |
| 20216607 | 20175077 | 1.8 | 80 | Palliative (P) | 2020-11-01 | 2020-11-02 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100611291 |
| 20216617 | 20175078 | 1.88 | 79.3 | Palliative (P) | 2021-03-17 | 2021-08-03 | ECX | 02 | Y | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100315977 |
| 20216621 | 20175079 | 1.65 | 82.3 | Palliative (P) | 2020-07-07 | 2021-02-26 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101826216 |
| 20216624 | 20175080 | 1.82 | 96.6 | Palliative (P) | 2021-07-30 | 2021-08-04 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101680703 |
| 20216640 | 20175081 | 1.7 | 64.2 | null | 2017-09-20 | 2017-09-22 | HCX | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101216275 |
| 20216655 | 20175082 | 1.8 | 60.2 | Palliative (P) | null | 2022-02-18 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | N | N | CAPECITABINE + CARBOPLATIN | 100303594 |
| 20216662 | 20175083 | 1.59 | 91.1 | Adjuvant (A) | 2018-07-27 | 2018-07-27 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101184567 |
| 20216669 | 20175084 | 1.81 | 100 | Palliative (P) | 2020-04-08 | 2020-04-29 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101816080 |
| 20216687 | 20175085 | 1.8 | 67 | Palliative (P) | 2018-09-14 | 2018-10-04 | ECX | N | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100742205 |
| 20216722 | 20175086 | 1.76 | 58 | null | 2018-07-11 | 2018-07-23 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100987004 |
| 20216724 | 20175087 | 1.74 | 66.4 | Palliative (P) | 2016-11-08 | 2017-04-09 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100546967 |
| 20216731 | 20175088 | 1.67 | 89 | null | 2019-07-12 | 2020-10-17 | CAPECITABINE + CARBOPLATIN | 02 | null | CAPECITABINE + CARBOPLATIN | 100670296 |
| 20216736 | 20175089 | 1.79 | 87 | Palliative (P) | 2018-12-30 | 2019-08-04 | null | null | N | PANITUMUMAB | 101472208 |
| 20216865 | 20175093 | 1.77 | 77.5 | null | 2018-01-05 | 2018-01-06 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101333133 |
| 20216905 | 20175094 | 1.71 | 95 | null | 2018-03-10 | 2019-02-26 | ECX | N | null | ECX | 101603517 |
| 20216933 | 20175095 | 1.71 | 51.35 | null | 2019-10-20 | 2019-10-21 | Panitumumab | N | null | PANITUMUMAB | 101866015 |
| 20216941 | 20175096 | 1.55 | 80.2 | null | 2016-10-27 | 2016-11-24 | Panitumumab | N | null | PANITUMUMAB | 100150606 |
| 20216965 | 20175097 | null | null | Curative (C) | null | 2018-11-26 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 101527100 |
| 20217067 | 20175099 | 1.6 | 76 | Curative (C) | null | 2017-12-09 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 100618570 |
| 20217106 | 20175100 | 1.52 | 66 | null | 2019-07-27 | 2019-08-01 | null | 02 | null | NIVOLUMAB | 101305955 |
| 20217128 | 20175101 | 1.79 | 93 | null | 2017-01-01 | 2017-01-26 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101809178 |
| 20217135 | 20175102 | 1.82 | 66.2 | Palliative (P) | 2019-05-04 | 2019-05-29 | ECX | 2 | N | ECX | 100254772 |
| 20217181 | 20175103 | 1.86 | 67 | Curative (C) | 2019-03-02 | 2019-05-12 | null | N | N | ECX | 101238447 |
| 20217211 | 20175104 | 1.6 | 50.8 | Palliative (P) | 2016-08-28 | 2016-09-04 | null | 2 | N | ECX | 100599443 |
| 20217236 | 20175105 | 1.77 | 58.5 | null | null | 2017-10-06 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101329666 |
| 20217247 | 20175106 | 1.67 | 80 | null | 2020-11-16 | 2020-12-26 | null | null | null | ECX | 101338189 |
| 20217259 | 20175107 | null | null | Palliative (P) | 2020-05-01 | 2020-05-26 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101815664 |
| 20217298 | 20175108 | null | null | Adjuvant (A) | 2018-07-30 | 2018-07-30 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100257752 |
| 20217333 | 20175110 | 1.76 | 86.3 | Palliative (P) | null | 2018-02-21 | ECX | null | N | ECX | 100638633 |
| 20217342 | 20175111 | 1.7 | 85.1 | null | 2019-07-03 | 2019-07-22 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100110204 |
| 20217351 | 20175112 | 1.7 | 62.7 | Palliative (P) | 2019-01-19 | 2019-01-19 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CISPLATIN + FLUOROURACIL | 100628140 |
| 20217381 | 20175113 | null | null | Palliative (P) | 2019-12-26 | 2019-12-27 | null | 2 | N | CISPLATIN + FLUOROURACIL | 101505873 |
| 20217383 | 20175114 | 1.81 | 94.7 | null | null | 2020-02-09 | ECX | null | null | ECX | 100818464 |
| 20217419 | 20175116 | 1.6 | 71.5 | null | null | 2018-09-15 | Cisplatin + Fluorouracil + RT 5day | 02 | null | CISPLATIN + FLUOROURACIL | 100704174 |
| 20217439 | 20175117 | null | null | Neo-adjuvant (N) | 2021-11-02 | 2021-11-02 | null | 02 | N | PANITUMUMAB | 100767434 |
| 20217455 | 20175118 | 1.62 | 63 | null | 2018-03-13 | 2018-03-21 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100146658 |
| 20217475 | 20175120 | 1.72 | 89.8 | Adjuvant (A) | 2018-04-16 | 2018-05-21 | ECX | 02 | Y | ECX | 100839283 |
| 20217485 | 20175121 | 1.64 | 66.4 | Palliative (P) | 2017-10-30 | 2017-11-13 | Panitumumab | 02 | N | PANITUMUMAB | 100024653 |
| 20217492 | 20175123 | 1.77 | 87.9 | null | 2019-02-15 | 2019-03-05 | ECX | 02 | N | ECX | 100296646 |
| 20217517 | 20175124 | 1.83 | 68.6 | Palliative (P) | 2018-04-20 | 2018-06-10 | null | 02 | N | PANITUMUMAB | 100533196 |
| 20217552 | 20175125 | 1.66 | 75.6 | null | 2018-02-12 | 2018-02-12 | Panitumumab | null | null | PANITUMUMAB | 101496379 |
| 20217565 | 20175126 | null | null | Palliative (P) | 2017-10-08 | 2017-10-08 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | CISPLATIN + FLUOROURACIL | 101607613 |
| 20217588 | 20175127 | 1.73 | null | Palliative (P) | 2019-08-20 | 2019-09-16 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 101310422 |
| 20217593 | 20175128 | 1.62 | 50.6 | Palliative (P) | 2021-03-20 | 2021-03-31 | CARBOPLATIN + ETOPOSIDE | 02 | Y | CARBOPLATIN + ETOPOSIDE | 100792392 |
| 20217606 | 20175130 | null | null | Palliative (P) | 2022-05-16 | 2022-05-24 | Panitumumab | 02 | N | PANITUMUMAB | 101774989 |
| 20217625 | 20175132 | 1.76 | 100.3 | null | 2017-11-19 | 2017-12-09 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100644966 |
| 20217630 | 20175134 | 1.78 | 75.6 | Palliative (P) | 2016-06-08 | 2016-06-10 | ECX | null | N | ECX | 101483077 |